Skip to main content
Caplight Logo









Orfonyx Bio

Orfonyx Bio

Private
OxfordHealthcare & Life Scienceshttps://orfonyx.com/

Last Round

Seed

Apr 9, 2025

Company Overview

Orfonyx Bio operates in Healthcare & Life Sciences and is based in Oxford. It was founded in 2022.

Orfonyx Bio is a biotechnology company developing a new class of genetic medicines that enhance gene expression by targeting regulatory elements in untranslated regions of genes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Orfonyx Bio Comparables

Compare Orfonyx Bio with similar companies based on industry and business-model similarity.

Orfonyx Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ribometrix
86%
Rgenta Therapeutics
79%
Ochre Bio
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Orfonyx Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 9, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Stuart Milstein

Chief Scientific Officer

Executive Team

For institutional investors. Book with your work email.

Orfonyx Bio Investors

Notable investors and investment history

Orfonyx Bio investors
InvestorRounds
Oxford Science EnterprisesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 12, 2025

    Grew 43% QoQ from 7 to 10 employees.

  • Oct 24, 2024

    Grew 75% QoQ from 4 to 7 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Orfonyx Bio Filings

Explore SEC and related filing metadata, where available.

Orfonyx Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Orfonyx Bio's valuation, stock price, and market status.

Is Orfonyx Bio a public or private company?

Orfonyx Bio is a private company.

What is the current stock price of Orfonyx Bio?

Orfonyx Bio is a private company, so its shares have no public market price. Caplight tracks Orfonyx Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Orfonyx Bio worth (valuation)?

Valuation information for Orfonyx Bio is not publicly available.

Can I buy Orfonyx Bio stock?

Orfonyx Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Orfonyx Bio's last funding round?

Orfonyx Bio's most recent funding round was Seed on April 9, 2025.

Who are the main investors in Orfonyx Bio?

Key investors in Orfonyx Bio include Oxford Science Enterprises.

Will Orfonyx Bio IPO soon?

No public IPO plans have been announced for Orfonyx Bio.

How can I track Orfonyx Bio secondary market activity?

Caplight tracks bids, offers, and trades in Orfonyx Bio's shares on secondary markets.

Firmographic Details

HeadquartersOxford
Employee Range7
Year Founded2022
Last FundingApr 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?